ATE96666T1 - Etodolac zur hemmung von gelenkversteifung. - Google Patents

Etodolac zur hemmung von gelenkversteifung.

Info

Publication number
ATE96666T1
ATE96666T1 AT87309257T AT87309257T ATE96666T1 AT E96666 T1 ATE96666 T1 AT E96666T1 AT 87309257 T AT87309257 T AT 87309257T AT 87309257 T AT87309257 T AT 87309257T AT E96666 T1 ATE96666 T1 AT E96666T1
Authority
AT
Austria
Prior art keywords
etodolac
joint stiffening
inhibit joint
inhibit
stiffening
Prior art date
Application number
AT87309257T
Other languages
English (en)
Inventor
Paul Wooley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE96666T1 publication Critical patent/ATE96666T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT87309257T 1986-10-27 1987-10-20 Etodolac zur hemmung von gelenkversteifung. ATE96666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/923,373 US4710511A (en) 1986-10-27 1986-10-27 Etodolac for inhibition of joint ankylosis
EP19870309257 EP0266114B1 (de) 1986-10-27 1987-10-20 Etodolac zur Hemmung von Gelenkversteifung

Publications (1)

Publication Number Publication Date
ATE96666T1 true ATE96666T1 (de) 1993-11-15

Family

ID=25448579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309257T ATE96666T1 (de) 1986-10-27 1987-10-20 Etodolac zur hemmung von gelenkversteifung.

Country Status (8)

Country Link
US (1) US4710511A (de)
EP (1) EP0266114B1 (de)
JP (1) JP2585638B2 (de)
KR (1) KR950013755B1 (de)
AT (1) ATE96666T1 (de)
DE (1) DE3788035T2 (de)
DK (1) DK559487A (de)
ES (1) ES2059392T3 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533551A (en) * 1984-02-17 1985-08-06 American Home Products Corporation Method of treating arthritis with etodolac

Also Published As

Publication number Publication date
US4710511A (en) 1987-12-01
JP2585638B2 (ja) 1997-02-26
DK559487D0 (da) 1987-10-26
EP0266114A3 (en) 1990-05-09
JPS63126822A (ja) 1988-05-30
DE3788035T2 (de) 1994-03-03
KR880004813A (ko) 1988-06-27
ES2059392T3 (es) 1994-11-16
KR950013755B1 (ko) 1995-11-15
EP0266114B1 (de) 1993-11-03
EP0266114A2 (de) 1988-05-04
DE3788035D1 (de) 1993-12-09
DK559487A (da) 1988-04-28

Similar Documents

Publication Publication Date Title
BG60249B1 (bg) Тиазолово съединение за лечение на язви
KR890702089A (ko) 주기적 목표치에 최적하게 추종하는 제어방식
DE3884696D1 (de) Erzeugung von korrosionsbeständigen Stählen.
DE3773858D1 (de) Carbonylierungsverfahren von ungesaettigten acetylenverbindungen.
DK588486A (da) Anvendelse af en forbindelse til behandling af hypoxi
DE3484043D1 (de) Verfahren zur aufbereitung von immuninterferon.
DE68906309D1 (de) Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
IT1144981B (it) Circuito di regolazione di uno stimolatore funzionale o terapeutico
DE3883606D1 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
SE7806725L (sv) Forfarande for rening av avloppsvatten med hjelp av ett sorptionsmedel
UA7046A1 (uk) Спосіб одержання похідних циклопропана
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
DE3680507D1 (de) Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.
DE3678053D1 (de) Herstellungsverfahren von trifluoressigsaeurealkylestern.
DE3852246D1 (de) Ethyl-(+)-Apovincaminat zur Behandlung der Demyelinisierung klinischer Erscheinungen autoimmunen Ursprungs.
JPS54142195A (en) Refining of crude chlorophosphazene compound by water treatment
ATE96666T1 (de) Etodolac zur hemmung von gelenkversteifung.
HUT63734A (en) Fish-breeding method
DK396989A (da) Cycliske svovlforbindelser
ATE78686T1 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE68926918D1 (de) Regulierung der Genexpression
ATE121737T1 (de) Herstellung von enantiomeren des dropropizins.
KR860006065A (ko) 본체자면크기(body face size)치환에 따른 문자수식제어방식
ATE96667T1 (de) Verwendung von heterocyclischen verbindungen zur behandlung von depressionen.
SU1208623A1 (ru) Препарат для лечения копытной гнили "формакаст"

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee